<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"
                      "http://www.w3.org/TR/REC-html40/loose.dtd">
<html>
<head>
<title>extropians: Re: ECON/BIO: Exceptional Returns: The Exceptional</title>
<meta name="Author" content="Robin Hanson (rhanson@gmu.edu)">
<meta name="Subject" content="Re: ECON/BIO: Exceptional Returns: The Exceptional Value of America's Investment in Medical Research">
</head>
<body bgcolor="#FFFFFF" text="#000000">
<h1>Re: ECON/BIO: Exceptional Returns: The Exceptional Value of America's Investment in Medical Research</h1>
<!-- received="Wed Jan 24 14:20:49 2001" -->
<!-- isoreceived="20010124212049" -->
<!-- sent="Wed, 24 Jan 2001 16:19:00 -0500" -->
<!-- isosent="20010124211900" -->
<!-- name="Robin Hanson" -->
<!-- email="rhanson@gmu.edu" -->
<!-- subject="Re: ECON/BIO: Exceptional Returns: The Exceptional Value of America's Investment in Medical Research" -->
<!-- id="4.2.0.58.20010124151659.049e1ec0@mason.gmu.edu" -->
<!-- inreplyto="5.0.2.1.2.20010124002600.031d2c50@mail.flashcom.net" -->
<strong>From:</strong> Robin Hanson (<a href="mailto:rhanson@gmu.edu?Subject=Re:%20ECON/BIO:%20Exceptional%20Returns:%20The%20Exceptional%20Value%20of%20America's%20Investment%20in%20Medical%20Research&In-Reply-To=&lt;4.2.0.58.20010124151659.049e1ec0@mason.gmu.edu&gt;"><em>rhanson@gmu.edu</em></a>)<br>
<strong>Date:</strong> Wed Jan 24 2001 - 14:19:00 MST
<p>
<!-- next="start" -->
<ul>
<li><strong>Next message:</strong> <a href="2360.html">Brian D Williams: "SOC/BIO Re: George Will joins the BioLuddites"</a>
<li><strong>Previous message:</strong> <a href="2358.html">Barbara Lamar: "RE: meaning of life"</a>
<li><strong>In reply to:</strong> <a href="2302.html">Max More: "ECON/BIO: Exceptional Returns: The Exceptional Value of America's Investment in Medical Research"</a>
<!-- nextthread="start" -->
<!-- reply="end" -->
<li><strong>Messages sorted by:</strong> 
<a href="date.html#2359">[ date ]</a>
<a href="index.html#2359">[ thread ]</a>
<a href="subject.html#2359">[ subject ]</a>
<a href="author.html#2359">[ author ]</a>
</ul>
<hr noshade><p>
<!-- body="start" -->
<p>
Max More wrote:
<br>
<em>&gt;Exceptional Returns: The Economic Value of America's Investment in Medical 
</em><br>
<em>&gt;Research
</em><br>
<em>&gt;Full text of a May 2000 report based on a book authored by nine of 
</em><br>
<em>&gt;America's most distinguished economists to be published later this year. 
</em><br>
<em>&gt;The findings of these leading economists challenge us to think about an 
</em><br>
<em>&gt;entirely new way to value medical research and help us to understand the 
</em><br>
<em>&gt;enormous contribution of medical research to the American standard of 
</em><br>
<em>&gt;living (Full report available in Adobe PDF format, 642 KB -- see press 
</em><br>
<em>&gt;release for summary in HTML).
</em><br>
<em>&gt;You will need Adobe Acrobat reader software in order to view this PDF 
</em><br>
<em>&gt;format document.
</em><br>
<em>&gt;<a href="http://www.laskerfoundation.org/fundingfirst/papers/Funding20First.pdf">http://www.laskerfoundation.org/fundingfirst/papers/Funding20First.pdf</a>
</em><br>
<p>As the list's resident health economist (teaching it this semester),
<br>
I have to say I don't think this at all presents a balanced view of
<br>
the relevant literature.  Health is indeed very valuable, and health
<br>
has improved dramatically over the decades, but there is little
<br>
evidence that medicine deserves a large chunk of the credit.
<br>
<p>That report says:
<br>
<em>&gt;Cutler and Kadiyala focus on cardiovascular disease, the source of the
</em><br>
<em>&gt;greatest gains since 1970. Changes in survival rates in the immediate
</em><br>
<em>&gt;aftermath of acute events – heart attacks and strokes – are almost entirely
</em><br>
<em>&gt;a result of new technology, which puts a lower bound on the likely benefits
</em><br>
<em>&gt;from medical research at 20 percent of the reduction in mortality. And they
</em><br>
<em>&gt;estimate that another 13 percent is tied to new drug therapies that reduce
</em><br>
<em>&gt;blood pressure and cholesterol.
</em><br>
<p>The paper really just assumes, and does not show, that survival
<br>
rate increases are due to new tech. And even if they are right
<br>
on this, they offer no evidence to think that this cardio
<br>
fraction is representative of medicine in general.
<br>
<p><p><p>Robin Hanson  <a href="mailto:rhanson@gmu.edu?Subject=Re:%20ECON/BIO:%20Exceptional%20Returns:%20The%20Exceptional%20Value%20of%20America's%20Investment%20in%20Medical%20Research&In-Reply-To=&lt;4.2.0.58.20010124151659.049e1ec0@mason.gmu.edu&gt;">rhanson@gmu.edu</a>  <a href="http://hanson.gmu.edu">http://hanson.gmu.edu</a>
<br>
Asst. Prof. Economics, George Mason University
<br>
MSN 1D3, Carow Hall, Fairfax VA 22030-4444
<br>
703-993-2326  FAX: 703-993-2323
<br>
<p><!-- body="end" -->
<hr noshade>
<ul>
<!-- next="start" -->
<li><strong>Next message:</strong> <a href="2360.html">Brian D Williams: "SOC/BIO Re: George Will joins the BioLuddites"</a>
<li><strong>Previous message:</strong> <a href="2358.html">Barbara Lamar: "RE: meaning of life"</a>
<li><strong>In reply to:</strong> <a href="2302.html">Max More: "ECON/BIO: Exceptional Returns: The Exceptional Value of America's Investment in Medical Research"</a>
<!-- nextthread="start" -->
<!-- reply="end" -->
<li><strong>Messages sorted by:</strong> 
<a href="date.html#2359">[ date ]</a>
<a href="index.html#2359">[ thread ]</a>
<a href="subject.html#2359">[ subject ]</a>
<a href="author.html#2359">[ author ]</a>
</ul>
<!-- trailer="footer" -->
<hr noshade>
<p>
<small>
<em>
This archive was generated by <a href="http://www.hypermail.org/">hypermail 2b30</a> 
: <em>Mon May 28 2001 - 09:56:24 MDT</em>
</em>
</small>
</body>
</html>
